Steven Cohen’s Century Therapeutics IPSC Stock Holding History

Steven Cohen’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2M	Sell	4,980,526 -984,152	-16%	-$2.25M	0.01%	1169
2026 Q1	$13.5M	Buy	5,964,678 +3,047	+0.1%	+$6.41K	0.02%	1039
2025 Q4	$5.93M	Buy	+5,961,631	New	+$3.64M	0.01%	1714
2023 Q1	–	Sell	-82,100	Closed	-$421K	–	2390
2022 Q4	$421K	Sell	82,100 -83,100	-50%	-$784K	﹤0.01%	1165
2022 Q3	$1.63M	Sell	165,200 -315,800	-66%	-$3.33M	0.01%	970
2022 Q2	$4.04M	Buy	481,000 +13,610	+3%	+$133K	0.02%	763
2022 Q1	$5.88M	Buy	467,390 +56,590	+14%	+$750K	0.02%	657
2021 Q4	$6.51M	Buy	+410,800	New	+$7.72M	0.03%	618

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Steven Cohen's IPSC Position: Q2 2026 in Review

Steven Cohen reduced its Century Therapeutics (IPSC) stake by 16% in Q2 2026, selling an estimated $2.25M and leaving 4,980,526 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1169.

Steven Cohen first reported a position in IPSC in Q4 2021 and has held it in 8 quarters since. The position peaked at $13.5M in Q1 2026. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Steven Cohen held 4,980,526 shares of Century Therapeutics worth $12.2M as of Q2 2026.
Steven Cohen sold 984,152 Century Therapeutics shares in Q2 2026, an estimated $2.25M.
Century Therapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1169 holding.
Steven Cohen first reported a position in Century Therapeutics in Q4 2021 and has held it in 8 quarters since.
Steven Cohen's Century Therapeutics position peaked at $13.5M in Q1 2026.
98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.